Trials / Completed
CompletedNCT02738125
Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 265 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
This study assesses the long?term effectiveness of adalimumab in subjects starting a treatment for ulcerative colitis in real life conditions, namely to describe the time to loss of clinical benefit in a time to event approach.
Conditions
Timeline
- Start date
- 2016-04-29
- Primary completion
- 2023-12-15
- Completion
- 2023-12-15
- First posted
- 2016-04-14
- Last updated
- 2024-12-31
Locations
80 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02738125. Inclusion in this directory is not an endorsement.